# US 2025/0368680 A1 · Method for producing salt of amino acid or salt of peptide compound or solvate of either one of said salts comprising lithium salt precipitation step

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0368680 A1
- Document ID: US20250368680A1
- Status: Published application
- Kind: A1
- Application number: 18/864,049
- Filed: 2023-05-12
- Published: 2025-12-04
- Earliest claimed: 2022-05-13
- Assignees: Chugai Seiyaku Kabushiki Kaisha
- Applicants: Chugai Seiyaku Kabushiki Kaisha
- Inventors: Hirotaka EJIMA; Kiyomichi SHINODA
- Web page: https://patentgrep.com/patent/US20250368680A1

## CPC

- C07K 1/306: {by crystallization}
- C12N 9/0016: {with NAD or NADP as acceptor (1.4.1)}
- C07C 229/06: having only one amino and one carboxyl group bound to the carbon skeleton
- C07C 269/08: Separation; Purification; Stabilisation; Use of additives
- C07D 207/16: Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07K 1/303: {by salting out}
- C07K 1/36: by a combination of two or more processes of different types
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

One aspect of the present invention relates to a method for producing a salt of an amino acid or a salt of a peptide compound or a solvate thereof, comprising the following steps (A) and (B): step (A); a step of contacting a lithium-containing substance with a mixture to be purified which is a mixture of the following purification target (i) and the following impurities (ii): (i) the amino acid having a protective group at the N terminus or the peptide compound having a protective group at the N terminus, and (ii) compounds other than the purification target, and step (B); a step of precipitating a lithium salt of the purification target.

## Claims

### Claim at position 1

-15. (canceled)

### Claim 16

A method for producing a salt of an amino acid or a salt of a peptide compound or a solvate thereof, comprising the following steps (A) and (B):
step (A); a step of contacting a lithium-containing substance with a mixture to be purified which is a mixture of the following purification target (i) and the following impurities (ii):
(i) the amino acid having a protective group at the N terminus or the peptide compound having a protective group at the N terminus, and
(ii) compounds other than the purification target, and step (B); a step of precipitating a lithium salt of the purification target.

### Claim 17

A method for removing impurities from a mixture to be purified, comprising the following steps (A) and (B):
step (A); a step of contacting a lithium-containing substance with a mixture to be purified which is a mixture of the following purification target (i) and the following impurities (ii):
(i) an amino acid having a protective group at the N terminus or a peptide compound having a protective group at the N terminus, and
(ii) compounds other than the purification target, and step (B); a step of precipitating a lithium salt of the purification target.

### Claim 18 (depends on 16)

The method according to claim 16, wherein the protective group at the N terminus of the purification target is a carbamate-type protective group.

### Claim 19 (depends on 16)

The method according to claim 16, wherein the purification target has a fluorenylmethoxycarbonyl group, a tert-butoxycarbonyl group, a benzyloxycarbonyl group, an allyloxycarbonyl group, a 2,2,2-trichloroethoxycarbonyl group, or a 2-(trimethylsilyl) ethoxycarbonyl group.

### Claim 20 (depends on 16)

The method according to claim 16, wherein the impurities are amino acids having a protective group at the N terminus or peptide compounds having a protective group at the N terminus, other than the purification target.

### Claim 21 (depends on 16)

The method according to claim 16, wherein the impurities are β-alanine having a protective group at the N terminus.

### Claim 22 (depends on 16)

The method according to claim 16, wherein the lithium salt of the purification target is formed in the step (A).

### Claim 23 (depends on 16)

The method according to claim 16, wherein the lithium salt of the purification target or a solvate thereof is precipitated as a solid in the step (B).

### Claim 24 (depends on 16)

The method according to claim 16, wherein the lithium salt of the purification target or a solvate thereof is precipitated as crystals in the step (B).

### Claim 25 (depends on 16)

The method according to claim 16, wherein the step (A) is performed in the presence of a first organic solvent.

### Claim 26 (depends on 16)

The method according to claim 16, wherein the step (B) is performed in the presence of a second organic solvent.

### Claim 27 (depends on 16)

The method according to claim 16, wherein the step (B) is performed in the presence of water.

### Claim 28 (depends on 16)

The method according to claim 16, wherein the amino acid or an N-terminal amino acid constituting the peptide compound is represented by the following general formula (1):
wherein
in the general formula (1),
n represents a number of 1 or more and 3 or less,
when a plurality of R1 are present, R1 are the same as or different from each other,
R1 and R2 each represent a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group, a heterocyclyl group, or a heteroaryl group, or a substituent in which two or more selected from the group consisting of these substituents are bonded, these substituents optionally have a substituent, each of these groups is optionally a saturated hydrocarbon group or an unsaturated hydrocarbon group,
A represents a carbon atom,
B represents a hydrogen atom or a binding point to an amino acid or a peptide compound,
Z represents a fluorenylmethoxycarbonyl group, a tert-butoxycarbonyl group, a benzyloxycarbonyl group, an allyloxycarbonyl group, a 2,2,2-trichloroethoxycarbonyl group, or a 2-(trimethylsilyl) ethoxycarbonyl group,
R1 and R2 are optionally bonded to form a ring together with N and A, wherein each of R1 and R2 is a substituent having a structure obtained by eliminating one hydrogen atom from the structure of the substituent that is not involved in ring formation, and
when n is 2, at least one of R2 and two R1 is not a hydrogen atom.

### Claim 29 (depends on 16)

The method according to claim 16, wherein a purity of the precipitate obtained in the step (B) is 95% by mol or higher.

### Claim 30

A lithium salt of an amino acid or a lithium salt of a peptide compound or a solvate thereof, wherein
the lithium salt of an amino acid contains a lithium salt of an amino acid represented by the following general formula (1) with a purity of 99% by mol or higher or an apparent purity of 99% or higher, and
the lithium salt of a peptide compound contains a lithium salt of a peptide compound having a residue of an amino acid represented by the following general formula (1) with a purity of 99% by mol or higher or an apparent purity of 99%,
wherein
in the general formula (1),
n represents a number of 1 or more and 3 or less,
when a plurality of R1 are present, R1 are the same as or different from each other,
R1 and R2 each represent a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group, a heterocyclyl group, or a heteroaryl group, or a substituent in which two or more selected from the group consisting of these substituents are bonded, these substituents optionally have a substituent, each of these groups is optionally a saturated hydrocarbon group or an unsaturated hydrocarbon group,
A represents a carbon atom,
B represents a hydrogen atom or a binding point to an amino acid or a peptide compound,
Z represents a fluorenylmethoxycarbonyl group, a tert-butoxycarbonyl group, a benzyloxycarbonyl group, an allyloxycarbonyl group, a 2,2,2-trichloroethoxycarbonyl group, or a 2-(trimethylsilyl) ethoxycarbonyl group,
R1 and R2 are optionally bonded to form a ring together with N and A, wherein each of R1 and R2 is a substituent having a structure obtained by eliminating one hydrogen atom from the structure of the substituent that is not involved in ring formation, and
when n is 2, at least one of R2 and two R1 is not a hydrogen atom.
